Skip to content
Publicly Available Published online by De Gruyter October 26, 2016

Corrigendum to: Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder

Dominique Belpomme, Christine Campagnac and Philippe Irigaray
This erratum corrects the original online version which can be found here: https://doi.org/10.1515/10.1515/reveh-2015-0027

Corrigendum to: Dominique Belpomme, Christine Campagnac and Philippe Irigaray. Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two aspects of a unique pathological disorder. Reviews on Environmental Health 2015; volume 30, Issue 4, pp. 251–271. (DOI: 10.1515/reveh-2015-0027):

Since the publication of the article, some typographic errors – have been discovered but without impact on the content of the paper in Table 3: high-sensitivity C reactive protein (hs-CRP), immunoglobulin E (IgE), vitamin D2-D3 and histamine in the peripheral blood of EHS and/or MCS self-reporting patients, in Table 4: protein S100B and nitrotyrosin (NTT) in the peripheral blood of EHS and/or MCS self-reporting patients, and in Table 5: HSP70 and HSP27 chaperone proteins and anti-O-myelin autoantibodies in the peripheral blood of EHS and/or MCS self-reporting patients.

Table 3:

High-sensitivity C reactive protein (hs-CRP), immunoglobulin E (IgE), vitamin D2-D3 and histamine in the peripheral blood of EHS and/or MCS self-reporting patients.

Patients groupsEHSMCSEHS/MCS
n52152154
hs-CRP78 (14.97%)3 (5.77%)22 (14.29%)
>3 mg/L[3.27–51.91][3.5–10][3.27–21.61]
Vitamin D33 (6.33%)5 (9.62%)16 (10.39%)
<10 ng/mL[4.81–9.70][4.80–8.00][7.10–9.90]
Vitamin D300 (57.58%)25 (48.08%)92 (59.74%)
≥10 ng/mL and <30 ng/mL[10.40–29.70][10.70–27.90][15.00–28.60]
Histamine182/491 (37.07%)18/44 (40.91%)59/142 (41.55%)
>10 nmol/L[10.08–360.00][10.80–90.00][10.10–1797.50]
IgE115 (22.07%)8 (15.38%)38 (24.68%)
>100 UI/mL[101–1387.60][131.10–294.87][103.30–1200.00]

Note that for each biomarker the range of values is indicated in square brackets, e.g. [minimum-maximum]. In bold, corrected or adjusted values.

Table 4:

Protein S100B and nitrotyrosin (NTT) in the peripheral blood of EHS and/or MCS self-reporting patients.

Patients groupsEHSMCSEHS/MCS
n52152154
S100B73/495 (14.7%)6/51 (11.8%)28/142 (19.7%)
>0.105 μg/L[0.105–2.090][0.110–0.500][0.110–0.470]
NTT77/259 (29.7%)6/29 (20.7%)22/76 (28.9%)
>0.9 μg/mL[0.92–8.20][1.10–3.10][0.91–3.10]
Increased S100B and/or NTT133/250 (53.2%)12/22 (54.5%)46/73 (63%)
Increased histamine, S100B and/or NTT220/327 (67.3%)27/36 (75%)91/125 (72.8%)

Note that for each marker the range of values is indicated in square brackets, e.g. [minimum-maximum]. In bold, corrected or adjusted values.

Table 5:

HSP70 and HSP27 chaperone proteins and anti-O-myelin autoantibodies in the peripheral blood of EHS and/or MCS self-reporting patients.

Patients groupsEHSMCSEHS/MCS
n52152154
Hsp7091/486 (18.7%)4/52 (7.7%)36/142 (25.4%)
>5 ng/mL[5.90–11.20][7.10–7.70][5.20–32.20]
Hsp27123/476 (25.8%)6/52 (11.5%)42/132 (31.8%)
>5 ng/mL[5.20–11.20][5.90–9.20][5.10–25.00]
Hsp70 and/or Hsp27162/487 (33.3%)9/52 (17.3%)56/142 (39.4%)
Anti-O-myelin autoantibodies109/477 (22.9%)8/47 (17%)33/140 (23.6%)

Note that for each marker the range of values is indicated in square brackets, e.g. [minimum-maximum]. In bold, corrected or adjusted values.

The following provides the updated, corrected version of these tables. We apologize for any inconvenience caused.


Corresponding author: Philippe Irigaray, PhD, ARTAC, 57-59 rue de la convention, 75015 Paris, France, Phone: +33 (0)1 45 78 53 54, Fax: +33 (0)1 45 78 53 50

Published Online: 2016-10-26

©2016 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow